BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25353356)

  • 1. Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.
    Haas MK; Levy DN; Folkvord JM; Connick E
    AIDS Res Hum Retroviruses; 2015 Mar; 31(3):298-304. PubMed ID: 25353356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.
    Meditz AL; Haas MK; Folkvord JM; Melander K; Young R; McCarter M; Mawhinney S; Campbell TB; Lie Y; Coakley E; Levy DN; Connick E
    J Virol; 2011 Oct; 85(19):10189-200. PubMed ID: 21813616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells.
    Roy AM; Schweighardt B; Eckstein LA; Goldsmith MA; McCune JM
    J Acquir Immune Defic Syndr; 2005 Nov; 40(3):267-75. PubMed ID: 16249699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue.
    Gondois-Rey F; Grivel JC; Biancotto A; Pion M; Vigne R; Margolis LB; Hirsch I
    AIDS; 2002 Jun; 16(9):1245-9. PubMed ID: 12045489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CCR5
    Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
    BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
    Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
    J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
    Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
    J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
    Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection.
    Elsner RA; Ernst DN; Baumgarth N
    J Virol; 2012 Jul; 86(13):7146-57. PubMed ID: 22532671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.
    Terahara K; Ishige M; Ikeno S; Okada S; Kobayashi-Ishihara M; Ato M; Tsunetsugu-Yokota Y
    Microbes Infect; 2015 May; 17(5):378-86. PubMed ID: 25839960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro.
    Evans VA; Lal L; Akkina R; Solomon A; Wright E; Lewin SR; Cameron PU
    Retrovirology; 2011 Jun; 8():43. PubMed ID: 21639903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infection.
    Orlova-Fink N; Chowdhury FZ; Sun X; Harrington S; Rosenberg ES; Yu XG; Lichterfeld M
    AIDS; 2017 Oct; 31(16):2211-2215. PubMed ID: 28857825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.
    Popik W; Pitha PM
    J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines.
    Mariani SA; Brigida I; Kajaste-Rudnitski A; Ghezzi S; Rocchi A; Plebani A; Vicenzi E; Aiuti A; Poli G
    Blood; 2012 Mar; 119(9):2013-23. PubMed ID: 22234680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic induction of apoptosis in primary CD4(+) T cells by macrophage-tropic HIV-1 and TGF-beta1.
    Wang J; Guan E; Roderiquez G; Norcross MA
    J Immunol; 2001 Sep; 167(6):3360-6. PubMed ID: 11544326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.
    Watanabe S; Terashima K; Ohta S; Horibata S; Yajima M; Shiozawa Y; Dewan MZ; Yu Z; Ito M; Morio T; Shimizu N; Honda M; Yamamoto N
    Blood; 2007 Jan; 109(1):212-8. PubMed ID: 16954502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.